Avodart
Neoplasms, Prostate
Bay State Clinical Trials, Inc.Phase 4 / ApprovedDormant
BBB
75/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 61/ 100
- Competitive Position
- 95/ 100
Competitive context
514 Active assets in the Neoplasms, Prostate cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Desflurane Peter MacCallum Cancer Centre, Australia | Phase 4 | BBB |
Degarelix Bayer | Phase 4 | BBB |
PROPOFOL Peter MacCallum Cancer Centre, Australia | Phase 4 | BBB |
Flotufolastat F-18 Washington University School of Medicine | Phase 4 | BB |
VIPIVOTIDE TETRAXETAN Novartis Pharmaceuticals | Phase 4 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →